| Literature DB >> 26884794 |
Teresa Paolucci1, Carlo Baldari2, Manuela Di Franco3, Dario Didona3, Victor Reis4, Mario Vetrano5, Marco Iosa6, Domenica Trifoglio5, Federico Zangrando1, Ennio Spadini7, Vincenzo Maria Saraceni1, Laura Guidetti2.
Abstract
Introduction/Objective. Fibromyalgia might benefit from a specific tactile and proprioceptive rehabilitation approach. The aim of this study was to perform a randomized controlled trial to determine the efficacy of perceptual surfaces (PS) and physical exercises with regard to chronic pain and physical function in fibromyalgia compared with a control group. Methods. Data from 54 females (18-60 years old) with a diagnosis of fibromyalgia and scoring >5 on the visual analog scale were divided into 3 groups and analyzed: group treated with perceptual surfaces (PS-group), physical exercises group (PE-group), and control group (CG). The Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire (HAQ), and Fibromyalgia Assessment Scale (FAS) were administered at baseline (T0), at the end of the treatment (T1) (after 10 rehabilitation sessions over a 5-week period), and at the 12-week follow-up (T2). Results. The PS-group experienced a statistically significant improvement versus the CG in FAS and HAQ scores. Good efficacy with respect to pain and function in the PE-group compared with the CG in terms of FAS, HAQ, and FIQ scores was observed. The adherence ratio was 86% for the PE-group and CG and 90% for the PS-group. Conclusions. According to the results, the PS are as promising as the physical exercises, since results were similar.Entities:
Year: 2016 PMID: 26884794 PMCID: PMC4738703 DOI: 10.1155/2016/7574589
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flowchart.
Figure 2Perceptual surfaces and execution of a rehabilitation session.
Figure 3Execution of a session in the physical exercises group.
Group comparisons at baseline. Mean and standard deviations are reported. p values were computed using analysis of variance for continuous measures and Kruskal-Wallis analysis for VAS scores.
| Baseline parameter | PS-group | PE-group | CG |
|
|---|---|---|---|---|
| Age [years] | 49.3 ± 11.1 | 50.4 ± 8.6 | 51.3 ± 9.0 | 0.814 |
| Height [m] | 1.61 ± 0.06 | 1.62 ± 0.08 | 1.67 ± 0.08 | 0.055 |
| Weight [kg] | 66.4 ± 18.8 | 64.6 ± 9.2 | 68.6 ± 14.9 | 0.715 |
| Body mass index [kg/m2] | 25.5 ± 6.3 | 24.7 ± 3.7 | 23.8 ± 5.0 | 0.615 |
| VAS | 7.7 ± 1.3 | 6.9 ± 1.7 | 7.2 ± 1.8 | 0.482 |
| Duration of FM [years] | 6.23 ± 3.55 | 5.00 ± 1.04 | 5.12 ± 2.64 | 0.358 |
VAS: visual analog scale, SG: perceptive rehabilitation group, TG: rehabilitation group, and CG: control group.
Mean ± standard deviation of clinical scores for the three groups for the three assessment times. p values in the last column for each scale refer to within-group Friedman analysis, whereas the p values in the lower rows refer to group comparisons based on Kruskal-Wallis analysis, with upper and lower bounds of the 95% confidence interval (95% CI). p values are reported in bold if statistically significant. Effect size is reported in the last rows for the comparisons between groups.
| Scale | FIQ |
| FAS |
| HAQ |
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Time of assessment | T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 | |||
| PS-group | 68.0 ± 13.0 | 56.0 ± 13.0 | 55.0 ± 14.0 |
| 7.1 ± 1.2 | 5.8 ± 1.3 | 5.5 ± 1.6 |
| 1.1 ± 0.5 | 1.0 ± 0.6 | 0.9 ± 0.6 | 0.846 |
| PE-group | 66.0 ± 13.0 | 54.0 ± 10.0 | 54.0 ± 11.0 |
| 7.2 ± 1.3 | 6.0 ± 0.8 | 5.8 ± 0.8 |
| 1.3 ± 0.6 | 1.0 ± 0.6 | 0.9 ± 0.7 |
|
| CG | 64.0 ± 9.0 | 66.0 ± 10.0 | 66.0 ± 10.0 |
| 7.4 ± 1.2 | 7.0 ± 1.3 | 7.0 ± 1.4 | 0.128 | 1.3 ± 0.4 | 1.5 ± 0.4 | 1.6 ± 0.4 |
|
|
| ||||||||||||
|
| 0.329 |
|
| 0.865 |
|
| 0.282 |
|
| |||
|
| ||||||||||||
| 95% CI | ||||||||||||
| UB | 0.320 |
|
| 0.847 |
|
| 0.235 |
|
| |||
| LB | 0.380 |
|
| 0.889 |
|
| 0.289 |
|
| |||
|
| ||||||||||||
| ES | ||||||||||||
| PS-group and CG | 0.409 | −0.839 | −0.970 | −0.251 | −0.929 | −1.007 | −0.599 | −1.077 | −1.263 | |||
| PE-group and CG | 0.176 | −1.173 | −1.185 | −0.157 | −0.938 | −1.013 | 0.003 | −0.992 | −1.191 | |||
| PS-group and PE-group | −0.200 | 0.084 | 0.523 | 0.084 | 0.191 | 0.253 | 0.523 | 0.084 | −0.022 | |||
FIQ: Fibromyalgia Impact Questionnaire, FAS: Fibromyalgia Assessment Status, HAQ: Health Assessment Questionnaire, PS-group: perceptive surfaces group, PE: physical exercises group, CG: control group, T0: baseline, T1: end of the treatment, T2: follow-up, FR: Friedman analysis, KW: Kruskal-Wallis analysis, UB and LB: upper and lower bounds ES, and Cohen's d: effect size.
Figure 4Box and whiskers plots of FIQ (Fibromyalgia Impact Questionnaire), FAS (Fibromyalgia Assessment Status), and HAQ (Health Assessment Questionnaire) scores for the CG (control group), perceptual surfaces group (PS-group), and physical exercises group (PE-group) at the 3 assessments (T0, T1, and T2). The boxes show the lower quartile, median (middle line in box), and upper quartile values. The whiskers represent the most extreme values 1.5 times the interquartile range from the ends of the box, and the circles represent data with values beyond the ends of whiskers.